Your session is about to expire
← Back to Search
Mobile Health Intervention for Acute Kidney Injury in Children
N/A
Recruiting
Led By Rasheed Gbadegesin, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month
Awards & highlights
Study Summary
This trial is designed to help researchers learn more about how best to take care of patients with acute kidney injury (AKI), a condition that often leads to worse health outcomes.
Who is the study for?
This trial is for children aged 1 to 18 years who have been diagnosed with acute kidney injury (AKI) while in the hospital. It's not suitable for kids over 18 years and 11 months, those with cognitive impairments that prevent consent, non-English speakers, or those who are legally blind or deaf.Check my eligibility
What is being tested?
The study is testing a mobile health educational tool designed to improve care for children with AKI. The goal is to reduce negative health outcomes by providing patient-centered education through this technology.See study design
What are the potential side effects?
Since this intervention involves an educational tool rather than medication, traditional side effects are not expected. However, there may be indirect effects related to the usability and accessibility of the mobile tool.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute Kidney Injury (AKI) Knowledge Assessment score
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Receiving Educational ToolExperimental Treatment1 Intervention
Patients in this arm will receive the educational tool after the pretest in addition to usual care.
Group II: Receiving Usual CareActive Control1 Intervention
Patients in this arm will receive usual care after the pretest.
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,363 Previous Clinical Trials
3,420,484 Total Patients Enrolled
2 Trials studying Acute Kidney Injury
149 Patients Enrolled for Acute Kidney Injury
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,836 Previous Clinical Trials
47,850,832 Total Patients Enrolled
9 Trials studying Acute Kidney Injury
4,962 Patients Enrolled for Acute Kidney Injury
Rasheed Gbadegesin, MDPrincipal InvestigatorDuke University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am legally blind or deaf.I am between 1 and 18 years old.I was diagnosed with acute kidney injury while in the hospital.I have difficulty understanding or making decisions due to cognitive issues.I am at least 19 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Receiving Usual Care
- Group 2: Receiving Educational Tool
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger